BCL2 and cancer: Altered expression of miRNAs could control the chemosensitivity of cancer cells through either directly regulating apoptosis-related Bcl-2 family proteins to modify the cellular response to apoptosis initiated by chemotherapeutic agents, or modulating drug availability to influence the responsiveness of tumor cells indirectly [20,21,22,23].